Morning Overview

A daily sugary drink habit can quietly scar the liver like heavy drinking does

Liver damage is usually associated with heavy alcohol use, but one of the fastest-growing causes of liver disease has nothing to do with drinking. Diets high in sugar, and in particular a habit of consuming sugar-sweetened drinks such as soda, energy drinks and sweetened juices, are strongly linked to fatty liver disease, a condition that can progress from harmless fat accumulation to inflammation, scarring and, in some cases, cirrhosis. The end-stage damage can resemble what heavy alcohol inflicts, which is part of why the condition was long called non-alcoholic fatty liver disease. Researchers have singled out sugary beverages as a especially potent driver of the problem.

The shift has caught many people by surprise, because liver disease still carries a strong public association with alcohol rather than diet. Yet fatty liver disease has spread in step with rising rates of obesity and diabetes, and it now affects a large share of adults in wealthy countries, frequently without producing any early symptoms. Researchers studying the condition have paid particular attention to what people drink, since sweetened beverages deliver sugar in a form the body handles differently from the same sugar eaten in solid food.

What fatty liver disease is

Fatty liver disease begins when fat builds up inside liver cells in people who drink little or no alcohol. In its early stage the liver is enlarged with fat but not yet inflamed, a condition that often causes no symptoms and may be discovered only incidentally. In a subset of people, the fat triggers inflammation and cell injury, a more serious form that can lead to fibrosis, or scarring, and eventually cirrhosis and liver failure. The condition, historically termed non-alcoholic fatty liver disease and more recently reclassified by medical societies under the name metabolic dysfunction-associated steatotic liver disease, has become one of the most common chronic liver conditions worldwide, closely tied to rising rates of obesity and type 2 diabetes. Its silent early course is a large part of what makes it dangerous.

Why fructose is hard on the liver

The particular concern with sugary drinks lies in how the body handles fructose, one of the two sugars in the table sugar and high-fructose corn syrup used to sweeten them. Unlike glucose, which nearly every cell can burn for energy, fructose is metabolized mainly in the liver. When large amounts arrive quickly, as they do from a sweet drink swallowed in minutes, the liver converts the excess into fat through a process called de novo lipogenesis. Research supported by the National Institutes of Health has examined how high fructose intake can promote fat accumulation in the liver and disrupt its normal metabolism. As the NIH has reported, studies in animals and cells suggest that high fructose loads can impair the intestinal barrier and drive processes that fuel liver fat, offering a biological basis for the epidemiological link.

The special problem with beverages

Sugar in liquid form appears to be more harmful to the liver than the same sugar in solid food, and beverages are a leading reason. Drinks deliver a large dose of fructose rapidly and without the fiber, protein or fat that would slow absorption, sending a concentrated pulse to the liver. They also tend to add calories without producing the same feeling of fullness that solid food does, so they are easily consumed on top of an otherwise complete diet. Reviews of controlled trials have found that when sugar-sweetened beverages are consumed in amounts that add excess calories, markers of liver fat and liver injury, including the enzyme alanine aminotransferase, tend to rise. The pattern points to habitual, calorie-adding consumption of sweet drinks as a meaningful contributor to liver fat.

What the population studies show

Large observational studies have consistently associated higher intake of sugar-sweetened beverages with a greater likelihood of fatty liver disease. People who report drinking sugary beverages daily show elevated rates of the condition compared with those who rarely consume them, even after accounting for overall calorie intake and body weight in many analyses. The relationship holds across different populations and study designs, strengthening confidence that it is not merely a byproduct of sugary-drink consumers eating more in general. Clinical practice guidelines for preventing and managing fatty liver disease reflect this evidence, commonly recommending a reduction in added sugars and fructose alongside weight loss and increased physical activity as first-line measures.

How the damage can mirror alcohol

The comparison to heavy drinking is more than rhetorical. Non-alcoholic and alcohol-related fatty liver disease share a similar trajectory, from simple fat accumulation to inflammation, scarring and potentially cirrhosis, and under a microscope the tissue changes can look alike. Both conditions can progress silently for years before symptoms appear, and both can end in the same serious outcomes, including liver failure and an increased risk of liver cancer. The mechanisms differ in their starting point, alcohol versus dietary sugar and metabolic dysfunction, but the destination can be comparable. This overlap is why physicians describe sugar-driven fatty liver disease as capable of scarring the liver in ways that echo the damage from long-term alcohol use.

What the evidence suggests

The research does not indicate that an occasional soda causes liver disease, and fatty liver disease arises from a combination of factors including genetics, body weight, physical activity and overall diet. What the evidence does show is that a daily habit of sugar-sweetened beverages is a significant and modifiable contributor, one that public-health and liver-disease authorities increasingly emphasize. Because the early disease is usually silent, the damage can accumulate unnoticed until it is advanced. Reducing sugary-drink consumption is among the clearest, most actionable steps identified in the research for lowering the risk, which is why guidelines aimed at preventing fatty liver disease place it near the top of the list.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.


More from Morning Overview